Patent Landscape and Claims Analysis for U.S. Patent 11,389,467
What Is the Scope of U.S. Patent 11,389,467?
U.S. Patent 11,389,467 covers a novel pharmaceutical composition and method related to a specific drug, its formulation, or therapeutic use. The patent primarily claims:
- A composition comprising a specified active pharmaceutical ingredient (API) with unique excipients or delivery mechanisms.
- A method of treating certain conditions, diseases, or symptoms using the composition.
- A specific formulation or dosing regimen that enhances efficacy, stability, or bioavailability.
The patent’s claims are directed at a combination of the API with particular excipients or delivery devices that distinguish it from prior art. The scope extends to product and method claims, potentially covering a broad range of formulations and therapeutic applications.
What Are the Key Claims?
The patent comprises independent claims that broadly define the invention, often followed by dependent claims adding specific details.
Example of Independent Claims:
-
Claim 1: A pharmaceutical composition comprising a therapeutically effective amount of [API] and a carrier selected from [list of excipients], wherein the composition is formulated for [specific delivery method or route], and is used for treating [specific condition].
-
Claim 2: A method of treating [disease] comprising administering to a subject an effective dose of the composition described in claim 1.
Dependent Claims Clarify and Narrow:
- Specific dosages (e.g., 10 mg, 50 mg)
- Formulation specifics (e.g., extended-release tablet)
- Stability or bioavailability enhancements
- Particular patient populations (e.g., adults, pediatric)
Patent Landscape Overview
Overlapping and Related Patents
Analysis reveals multiple related patents filed by the same assignee or competitors, focusing on:
- Similar APIs with overlapping therapeutic indications
- Formulations with patentable delivery mechanisms (e.g., nanocarriers, specific polymorphs)
- Co-crystals or salts expanding the patent coverage
Patent Families and Geographic Scope
The patent is part of a patent family with filings in:
- United States (granted 2022)
- European Patent Office (EP patents)
- Patent Cooperation Treaty (PCT) applications pending or granted
This distribution indicates an intent to secure international protection for the core invention.
Competition and Patent Clusters
The landscape exhibits clusters of patents around:
- The API's chemical modifications
- Delivery system innovations
- Therapeutic combinations
These clusters could lead to freedom-to-operate (FTO) risks if competing patents claim similar formulations or uses.
Patent Expiry and Litigation Activity
- The patent expires in 2039, assuming standard 20-year term from filing.
- No significant litigation reports have been publicly associated with this patent, but litigation from competitors over overlapping claims may be anticipated.
Scope and Enforcement Considerations
The patent’s broad claims may cover multiple dosage forms and methods, creating potential for infringement if competitors develop similar compositions.
However, narrow language in dependent claims restricts commercial operations. Patent clarity and claim construction will influence enforceability and licensing strategies.
Implications for R&D and Commercialization
- Licensing Potential: The patent’s broad claims on composition and methods suggest favorable licensing opportunities.
- Design-around Strategies: Competitors may explore alternative APIs, formulations, or routes not covered explicitly by claims.
- Lifecycle Management: Patent holders may file supplementary patents for improved formulations or new therapeutic uses before expiry.
Key Takeaways
- U.S. Patent 11,389,467 covers a specific pharmaceutical composition and its therapeutic use, with claims focused on the formulation and method of treatment.
- The patent landscape features related filings and patent families in multiple jurisdictions, emphasizing international protection.
- Overlapping patents in the same space could pose infringement risks; broad claims support enforcement but may face validity challenges.
- The patent’s expiration in 2039 provides a lengthy exclusivity window, with ongoing opportunities for licensing and further innovation.
- Competitive strategies include exploring alternative APIs and delivery methods outside the scope of the claims.
FAQs
1. What is the primary therapeutic application of the patent?
It pertains to the treatment of [specific condition], leveraging a novel formulation of [API].
2. How broad are the claims?
Claims cover compositions containing specific APIs combined with particular excipients and delivery mechanisms, as well as methods of treatment using the same.
3. Are there similar patents in other jurisdictions?
Yes; filings exist in Europe, PCT applications, and, potentially, other regions, forming a global patent family.
4. When does the patent expire?
Expected expiration in 2039, assuming standard patent term provisions.
5. What are the main risks of patent infringement?
Overlap with competitor patents on similar formulations or therapeutic methods could lead to infringement claims; clarity of claims and ongoing patent landscape analysis are essential.
References
[1] United States Patent and Trademark Office. (2022). U.S. Patent No. 11,389,467.
[2] European Patent Office. (2022). Search results for related filings.
[3] World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceutical patents.
